Title Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
Authors Ye, Lifang
Zuo, Yu
Chen, Fang
Xu, Yuetong
Zhang, Puli
Yang, Hongxia
Lin, Sang
Peng, Qinglin
Wang, Guochun
Shu, Xiaoming
Affiliation China Japan Friendship Hosp, Dept Rheumatol, Key Lab Myositis, Beijing, Peoples R China
Chinese Acad Med Sci, Peking Union Med Coll, Peking Union Med Coll, Grad Sch, Beijing, Peoples R China
Peking Univ, China Japan Friendship Sch Clin Med, Beijing, Peoples R China
Keywords IDIOPATHIC INFLAMMATORY MYOPATHIES
METABOLIC SYNDROME
POLYMYOSITIS
ADIPOKINE
LUPUS
PREVALENCE
Issue Date 3-May-2022
Publisher FRONTIERS IN MEDICINE
Abstract ObjectiveIn the current study, we aimed to assess resistin mRNA levels in the peripheral blood mononuclear cells (PBMCs) of dermatomyositis patients with interstitial lung disease (DM-ILD) and their correlation with disease activity. MethodsWe detected resistin mRNA levels in the PBMCs of 37 DM-ILD, 8 DM patients without ILD, and 19 healthy control (HC) subjects by performing quantitative reverse transcription real-time polymerase chain reaction analysis. Associations between resistin expression levels and major clinical manifestations, laboratory examinations, and disease activity were also analyzed. In addition, resistin expression in lung specimens from patients with DM-ILD was examined via immunohistochemistry and immunofluorescence. ResultsResistin mRNA levels in PBMCs were significantly higher in DM-ILD than that in DM patients without ILD and HCs (p = 0.043, 0.014, respectively). Among these DM-ILD patients, the resistin levels were significantly elevated in those with rapidly progressive ILD than in those with chronic ILD (p = 0.012). The resistin mRNA levels in DM-ILD positively correlated with serum alanine aminotransferase (r = 0.476, p = 0.003), aspartate aminotransferase (r = 0.488, p = 0.002), lactate dehydrogenase (r = 0.397, p = 0.014), C-reactive protein (r = 0.423, p = 0.008), ferritin (r = 0.468, p = 0.003), carcinoembryonic antigen (r = 0.416, p = 0.011), carbohydrate antigen 125 (r = 0.332, p = 0.047), interleukin-18 (r = 0.600, p < 0.001), and lung visual analog scale values (r = 0.326, p = 0.048), but negatively correlated with the diffusing capacity of carbon monoxide (DLco)% (r = -0.447, p = 0.041). Immunohistochemical analysis of resistin showed its elevated expression in the macrophages, alveolar epithelial cells, and weak fibrotic lesions from patients with DM-ILD. Immunofluorescence staining confirmed CD68+ macrophages co-express resistin. ConclusionsResistin levels were increased in patients with DM-ILD and associated with disease activity and ILD severity. Therefore, resistin may participate in the pathogenesis of DM-ILD and may act as a useful biomarker.
URI http://hdl.handle.net/20.500.11897/643556
DOI 10.3389/fmed.2022.903887
Indexed SCI(E)
Appears in Collections: 中日友好医院

Files in This Work
There are no files associated with this item.

Web of Science®


0

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.